| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Apr―11 |
The influence of SARS-CoV-2 spike protein exposure on retinal development in the human retinal organoids |
Jing Gong, Lingling Ge, Yuxiao Zeng, Cao Yang, Yushan Luo, Jiahui Kang, Ting Zou, Haiwei Xu |
| 2 |
[GO] |
2024―Dez―20 |
The inactivation of the Niemann Pick C1 cholesterol transporter restricts SARS-CoV-2 entry into host cells by decreasing ACE2 abundance at the plasma membrane |
Piergiorgio La Rosa, Jessica Tiberi, Enrico Palermo, Roberta Stefanelli, Sofia Maria Luigia Tiano, Sonia Canterini, Mirko Cortese, John Hiscott, Maria Teresa Fiorenza |
| 3 |
[GO] |
2024―Sep―06 |
Targeting stress induction of GRP78 by cardiac glycoside oleandrin dually suppresses cancer and COVID-19 |
Dat P. Ha, Woo-Jin Shin, Ze Liu, Michael E. Doche, Roy Lau, Nektaria Maria Leli, Crystal S. Conn, Mariangela Russo, Annalisa Lorenzato, Constantinos Koumenis, Min Yu, Shannon M. Mumenthaler, Amy S. Lee |
| 4 |
[GO] |
2024―Aug―02 |
SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo |
Bobo Wing-Yee Mok, Maxwell Kwok, Hung Sing Li, Lowell Ling, Angel Lai, Bin Yan, Cherie Tsz-Yiu Law, Chui Him Yeung, Anna Jinxia Zhang, Rachel Chun-Yee Tam, Anja Kukic, Conor J. Cremin, Yajie Zhang, Teng Long, Zhisen Kang, Ruibang Luo, Kam Tong Leung, Albert M. Li, Grace Lui, Stephen Kwok-Wing Tsui, Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Paul K. S. Chan, Bryan P. Yan, Honglin Chen, Ellen Ngar-Yun Poon |
| 5 |
[GO] |
2023―Nov―14 |
Coffee as a dietary strategy to prevent SARS-CoV-2 infection |
Chen-Shiou Wu, Yi-Chuan Li, Shin-Lei Peng, Chung-Yu Chen, Hsiao-Fan Chen, Po-Ren Hsueh, Wei-Jan Wang, Yen-Yi Liu, Ciao-Ling Jiang, Wei-Chao Chang, Shao-Chun Wang, Mien-Chie Hung |
| 6 |
[GO] |
2023―Aug―31 |
Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies |
Yanning Wang, Tianyun Gao, WanTing Li, Chenxu Tai, Yuanyuan Xie, Dong Chen, Shuo Liu, Feifei Huang, Wenqing Wang, Yuxin Chen, Bin Wang |
| 7 |
[GO] |
2023―Jun―28 |
Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2 |
Fang-Ju Cheng, Chien-Yi Ho, Tzong-Shiun Li, Yeh Chen, Yi-Lun Yeh, Ya-Ling Wei, Thanh Kieu Huynh, Bo-Rong Chen, Hung-Yu Ko, Chen-Si Hsueh, Ming Tan, Yang-Chang Wu, Hui-Chi Huang, Chih-Hsin Tang, Chia-Hung Chen, Chih-Yen Tu, Wei-Chien Huang |
| 8 |
[GO] |
2022―Okt―01 |
Revisiting potential value of antitumor drugs in the treatment of COVID-19 |
Wenfang Zheng, Zekun Zeng, Shumei Lin, Peng Hou |
| 9 |
[GO] |
2022―Jun―11 |
Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection |
Saiaditya Badeti, Qingkui Jiang, Alireza Naghizadeh, Hsiang-chi Tseng, Yuri Bushkin, Salvatore A. E. Marras, Annuurun Nisa, Sanjay Tyagi, Fei Chen, Peter Romanienko, Ghassan Yehia, Deborah Evans, Moises Lopez-Gonzalez, David Alland, Riccardo Russo, William Gause, Lanbo Shi, Dongfang Liu |
| 10 |
[GO] |
2022―Mai―19 |
Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease |
Dongsheng Li, Gangan Yan, Wenwen Zhou, Shuyi Si, Xiaoping Liu, Jing Zhang, Yan Li, Yunyu Chen |
| 11 |
[GO] |
2022―Mai―17 |
Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants |
Lili Li, Meiling Gao, Peng Jiao, Shulong Zu, Yong-qiang Deng, Dingyi Wan, Yang Cao, Jing Duan, Saba R Aliyari, Jie Li, Yueyue Shi, Zihe Rao, Cheng-feng Qin, Yu Guo, Genhong Cheng, Heng Yang |
| 12 |
[GO] |
2022―Mrz―22 |
SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1 |
Sin-Yee Fung, Kam-Leung Siu, Huayue Lin, Ching-Ping Chan, Man Lung Yeung, Dong-Yan Jin |
| 13 |
[GO] |
2022―Mrz―20 |
Diabetes as a potential compounding factor in COVID-19-mediated male subfertility |
Qingkui Jiang, Thomas Linn, Karl Drlica, Lanbo Shi |
| 14 |
[GO] |
2022―Feb―09 |
Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients |
Jiuxin Qu, Zhao Cai, Xiangke Duan, Han Zhang, Hang Cheng, Shuhong Han, Kaiwei Yu, Zhaofang Jiang, Yingdan Zhang, Yang Liu, Fang Bai, Yingxia Liu, Lei Liu, Liang Yang |
| 15 |
[GO] |
2022―Feb―09 |
Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis |
Weiping Ji, Lu Chen, Wei Yang, Ke Li, Jingting Zhao, Congcong Yan, Cancan You, Minghua Jiang, Meng Zhou, Xian Shen |
| 16 |
[GO] |
2021―Dez―18 |
SARS-CoV-2 and COVID-19: revisiting the most important research questions |
Kit-San Yuen, Zi-Wei Ye, Sin-Yee Fung, Pak-Hin Hinson Cheung, Chi-Ping Chan, Dong-Yan Jin |
| 17 |
[GO] |
2021―Dez―08 |
Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2 |
Huibi Cao, Juntao Mai, Zhichang Zhou, Zhijie Li, Rongqi Duan, Jacqueline Watt, Ziyan Chen, Ranmal Avinash Bandara, Ming Li, Sang Kyun Ahn, Betty Poon, Natasha Christie-Holmes, Scott D. Gray-Owen, Arinjay Banerjee, Karen Mossman, Rob Kozak, Samira Mubareka, James M. Rini, Jim Hu, Jun Liu |
| 18 |
[GO] |
2021―Dez―05 |
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors |
Gangan Yan, Dongsheng Li, Yuan Lin, Zhenghao Fu, Haiyan Qi, Xiaoping Liu, Jing Zhang, Shuyi Si, Yunyu Chen |
| 19 |
[GO] |
2021―Nov―21 |
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients |
Cong Zeng, John P. Evans, Sarah Reisinger, Jennifer Woyach, Christina Liscynesky, Zeinab El Boghdadly, Mark P. Rubinstein, Karthik Chakravarthy, Linda Saif, Eugene M. Oltz, Richard J. Gumina, Peter G. Shields, Zihai Li, Shan-Lu Liu |
| 20 |
[GO] |
2021―Sep―08 |
Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets |
Xu Pan, Xin Li, Shangwei Ning, Hui Zhi |
| 21 |
[GO] |
2021―Aug―30 |
Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor |
Jinbiao Liu, Brittany H. Bodnar, Fengzhen Meng, Adil I. Khan, Xu Wang, Sami Saribas, Tao Wang, Saroj Chandra Lohani, Peng Wang, Zhengyu Wei, Jinjun Luo, Lina Zhou, Jianguo Wu, Guangxiang Luo, Qingsheng Li, Wenhui Hu, Wenzhe Ho |
| 22 |
[GO] |
2021―Aug―22 |
An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection |
Azadeh Safarchi, Shadma Fatima, Zahra Ayati, Fatemeh Vafaee |
| 23 |
[GO] |
2021―Jul―22 |
Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication |
Yiling Jiang, Kuijie Tong, Roubin Yao, Yuanze Zhou, Hanwen Lin, Liubing Du, Yunyun Jin, Liu Cao, Jingquan Tan, Xing-Ding Zhang, Deyin Guo, Ji-An Pan, Xiaoxue Peng |
| 24 |
[GO] |
2021―Jul―19 |
Differing susceptibility of C57BL/6J and DBA/2J mice-parents of the murine BXD family, to severe acute respiratory syndrome coronavirus infection |
Kui Li, Yang Shen, Mark A. Miller, Jennifer Stabenow, Robert W. Williams, Lu Lu |
| 25 |
[GO] |
2021―Jul―19 |
SARS-CoV-2: from its discovery to genome structure, transcription, and replication |
Ayslan Castro Brant, Wei Tian, Vladimir Majerciak, Wei Yang, Zhi-Ming Zheng |
| 26 |
[GO] |
2021―Jul―08 |
A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses |
Yanxing Cai, Wei Xu, Jiayi Tang, Najing Cao, Qiaoshuai Lan, Lu Lu, Shibo Jiang |
| 27 |
[GO] |
2021―Jun―23 |
Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion |
Xuening Wang, Chih-Hsiung Chen, Saiaditya Badeti, Jong Hyun Cho, Alireza Naghizadeh, Ziren Wang, Dongfang Liu |
| 28 |
[GO] |
2021―Jun―13 |
Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2 |
Joyce van de Leemput, Zhe Han |
| 29 |
[GO] |
2021―Mrz―25 |
Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment |
Jun-yi Zhu, Jin-Gu Lee, Joyce van de Leemput, Hangnoh Lee, Zhe Han |
| 30 |
[GO] |
2021―Mrz―25 |
Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor |
Jin-Gu Lee, Weiliang Huang, Hangnoh Lee, Joyce van de Leemput, Maureen A. Kane, Zhe Han |
| 31 |
[GO] |
2021―Feb―28 |
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases |
Zinuo Chen, Qinghua Cui, Laura Cooper, Pin Zhang, Hyun Lee, Zhaoyu Chen, Yanyan Wang, Xiaoyun Liu, Lijun Rong, Ruikun Du |
| 32 |
[GO] |
2020―Dez―30 |
ACE2: the molecular doorway to SARS-CoV-2 |
Miriam Marlene Medina-Enríquez, Sandra Lopez-León, José Alberto Carlos-Escalante, Zuleika Aponte-Torres, Angelica Cuapio, Talia Wegman-Ostrosky |
| 33 |
[GO] |
2020―Mrz―16 |
SARS-CoV-2 and COVID-19: The most important research questions |
Kit-San Yuen, Zi -Wei Ye, Sin-Yee Fung, Chi-Ping Chan, Dong-Yan Jin |
|
